✦ LIBER ✦

JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical

✍ Scribed by Tanaka, Yoshiya; Yamaoka, Kunihiro

Book ID: 120061343
Publisher: Springer
Year: 2012
Tongue: English
Weight: 530 KB
Volume: 23
Category: Article
ISSN: 1439-7595
DOI: 10.1007/s10165-012-0799-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tofacitinib: The First Janus Kinase (JAK

Tofacitinib: The First Janus Kinase (JAK) Inhibitor for the Treatment of Rheumatoid Arthritis

✍ Vyas, Deepti (author);O'Dell, Kate M. (author);Bandy, Jason L. (author);Boyce, E 📂 Article 📅 2013 🏛 Harvey Whitney Books Company 🌐 English ⚖ 293 KB

Tofacitinib: The First Janus Kinase (JAK

Tofacitinib: The First Janus Kinase (JAK) Inhibitor for the Treatment of Rheumatoid Arthritis

✍ Vyas, Deepti (author);O'Dell, Kate M. (author);Bandy, Jason L. (author);Boyce, E 📂 Article 📅 2013 🏛 Harvey Whitney Books Company 🌐 English ⚖ 293 KB

Preclinical to Clinical Translation of T

Preclinical to Clinical Translation of Tofacitinib, a Janus Kinase Inhibitor, in Rheumatoid Arthritis

✍ Dowty, M. E.; Jesson, M. I.; Ghosh, S.; Lee, J.; Meyer, D. M.; Krishnaswami, S.; 📂 Article 📅 2013 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 574 KB

Exposure-response modeling using latent

Exposure-response modeling using latent variables for the efficacy of a JAK3 inhibitor administered to rheumatoid arthritis patients

✍ Matthew M. Hutmacher; Sriram Krishnaswami; Kenneth G. Kowalski 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 491 KB

From desk to bed: Computational simulati

From desk to bed: Computational simulations provide indication for rheumatoid arthritis clinical trials

✍ Jennifer E Dent, Christine Nardini 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 192 KB

Phase IIb dose-ranging study of the oral

Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs

✍ Roy Fleischmann; Maurizio Cutolo; Mark C. Genovese; Eun Bong Lee; Keith S. Kanik 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 4 views